📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-30 16:47
0 analysed today
FollowTelegram
0
Today
151,853
All-time analysed
43,533
Positive
6,742
Negative
92,741
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
5 announcements match the current filters (relevance ≥ 5).
Agribio Spirits Shareholders Approve 3% (₹0.30/Share) Final Dividend for FY26
Agribio Spirits Limited announced that shareholders approved Agenda No. 2 for the declaration of a final dividend at its Annual General Meeting held on September 30, 2026. As per exchange details, the dividend is approved at 3% (₹0.30 per equity share) for the financial year ended March 31, 2026. Against the company's FY26 net profit of ₹4.06 crore and TTM EPS of ₹3.73, this represents a modest payout. The meeting was conducted at the company's corporate office in Jaipur.
Confidence: HIGH
What changedShareholders formally approved the final dividend for FY26 at the AGM held on September 30, 2026.
Why it mattersConfirms the corporate payout to shareholders; however, with a dividend of ₹0.30 per share on a ₹314.2 stock price, the dividend yield remains marginal at under 0.1%.
Final Dividend per Share: Rs. 0.30Dividend Percentage: 3%Dividend Yield on CMP: ~0.1%AGM Date: 30th day of September, 2026
📅 Short termLimited share price impact expected as shareholder approval of the FY26 final dividend is routine and yield is low.
📈 Long termLimited; company's long-term performance remains tied to operating margins and revenue execution given historical negative operating margins (-1.02% in FY26).
⚠ Risk flags
- Low operating profitability (FY26 OPM at -1.02%)
- High P/E multiple (84.2x) relative to underlying earnings
Key Highlights
Shareholders approved final dividend of 3% (₹0.30 per equity share) for FY26
AGM held on September 30, 2026 at 11:30 A.M. in Jaipur
Company reported FY26 Net Profit of ₹4.06 crore and EPS of ₹3.73
Current market cap stands at ₹342 crore with a stock price of ₹314.2
👀 What to Watch
Track the record date and payout schedule for the dividend credit, along with upcoming Q2 FY27 earnings for operating performance updates.
Agribio Spirits Convenes NCLT Shareholder Meeting on Oct 24, 2026 for Agribiotech Merger
Agribio Spirits Limited has issued a notice convening a meeting of equity shareholders on October 24, 2026, pursuant to NCLT Jaipur Bench orders dated August 13 and September 3, 2026. The meeting will consider and vote on the scheme of amalgamation of Agribiotech Industries Limited (Transferor Company) into Agribio Spirits Limited (Transferee Company). Remote e-voting is scheduled from October 19 to October 23, 2026. This merger is a major structural event for Agribio Spirits, which currently holds a market cap of Rs 342 Cr and FY26 revenue of Rs 45 Cr.
Confidence: HIGH
What changedAgribio Spirits formally convened the NCLT-ordered meeting of equity shareholders to vote on the merger of Agribiotech Industries Limited.
Why it mattersThe amalgamation will integrate Agribiotech Industries into Agribio Spirits, potentially altering the capital structure, asset base, and scale of the business relative to its current Rs 342 Cr market capitalization.
Meeting Date: 24th October, 2026Remote E-voting Start: 19th October, 2026Remote E-voting End: 23rd October, 2026Current Market Cap: Rs 342 Cr
📅 Short termShareholder voting and attendance between October 19 and October 24, 2026, will be the immediate focus, alongside scrutineer report disclosures.
📈 Long termIf approved by shareholders and NCLT, the combined entity could see significant changes in operational scale, capacity, and revenue profile compared to its standalone TTM revenue of Rs 45 Cr.
⚠ Risk flags
- Shareholder or creditor rejection risks
- Regulatory and final NCLT approval hurdles
- Integration execution risks post-amalgamation
Key Highlights
Shareholder meeting scheduled for Saturday, October 24, 2026, at 3:00 PM IST via physical and VC/OAVM modes
Remote e-voting window opens on October 19, 2026 (9:00 AM) and closes on October 23, 2026 (5:00 PM)
Convened pursuant to Hon'ble NCLT Jaipur Bench orders dated August 13, 2026, and September 3, 2026
Scheme involves the merger of Agribiotech Industries Limited into listed entity Agribio Spirits Limited
👀 What to Watch
Track the outcome of the equity shareholder vote on October 24, 2026, followed by subsequent final approval sanctions from NCLT Jaipur Bench.
NCLT Jaipur Directs Shareholder & Creditor Meetings for Agribio Spirits Amalgamation
Agribio Spirits Limited has received an order dated August 13, 2026, from the NCLT Jaipur Bench concerning its proposed Scheme of Amalgamation with Agribiotech Industries Limited. The tribunal directed both the transferor and transferee companies to convene meetings of their respective equity shareholders, secured creditors, and unsecured creditors to approve the scheme. Specific dates, times, and modes for these meetings will be notified separately. The company currently has a market cap of Rs 347 Cr and TTM revenue of Rs 45 Cr.
Confidence: HIGH
What changedNCLT Jaipur Bench issued directions to convene stakeholder and creditor meetings to vote on the proposed amalgamation scheme.
Why it mattersRepresents a key procedural step toward integrating Agribiotech Industries into Agribio Spirits, potentially expanding operational scale beyond its current Rs 45 Cr TTM revenue base.
NCLT Order Date: August 13, 2026Market Cap: Rs 347 CrTTM Revenue: Rs 45 Cr
📅 Short termThe announcement marks positive procedural progress; near-term focus will be on the notification of meeting dates and proxy voting materials.
📈 Long termIf approved by stakeholders and ultimately sanctioned by the NCLT, the amalgamation could structurally consolidate related business operations under the listed entity.
⚠ Risk flags
- Shareholder and creditor approval hurdles
- Subsequent final sanction from NCLT required
- Exact financial impact and share exchange details not stated in this update
Key Highlights
Hon'ble NCLT Jaipur Bench passed an order on August 13, 2026, advancing the Scheme of Amalgamation.
Meetings of Equity Shareholders, Secured Creditors, and Unsecured Creditors directed for both Transferor and Transferee entities.
Involves merger of Agribiotech Industries Limited into Agribio Spirits Limited.
Detailed schedule including date, time, and venue/mode of meetings to be communicated separately.
👀 What to Watch
Track subsequent filings for the formal notice of shareholder/creditor meetings, voting timeline, and the final share swap ratio.
Q1 FY27 Cons. PAT Rises 23.2% YoY to ₹1.21 Cr; Standalone Revenue Drops to ₹0.62 Cr
Agribio Spirits reported a consolidated net profit of ₹1.21 Cr (₹120.99 Lacs) for Q1 ended June 30, 2026, marking a 23.2% YoY growth from ₹0.98 Cr. Consolidated profitability was heavily supported by a ₹0.92 Cr (₹91.66 Lacs) share of profit from its 29.76% associate company. In contrast, standalone operations saw revenue plunge 91.6% YoY to ₹0.62 Cr from ₹7.36 Cr, driving standalone PAT down 42.7% YoY to ₹0.24 Cr. The company's proposed merger by absorption with Agribiotech Industries Limited remains pending before the NCLT.
Confidence: HIGH
What changedQ1 FY27 consolidated earnings improved driven by associate income, while standalone core revenue shrank sharply to ₹0.62 Cr.
Why it mattersGiven the rich valuation (P/E ~85x), operational growth depends heavily on completing the pending merger of Agribiotech Industries to establish direct scale beyond associate contributions.
Consolidated PAT (Q1 FY27): ₹1.21 CrStandalone Revenue (Q1 FY27): ₹0.62 CrShare of Profit from Associate: ₹0.92 CrConsolidated EPS (Q1 FY27): ₹1.11
📅 Short termPerformance may draw mixed sentiment as higher consolidated PAT is overshadowed by a severe decline in direct standalone business revenues.
📈 Long termLong-term value creation depends entirely on successful integration and execution post the NCLT approval of the Agribiotech Industries merger.
⚠ Risk flags
- Severe drop in standalone top-line revenue (-91.6% YoY)
- Heavy reliance on associate company profits (over 74% of consolidated PBT)
- Regulatory execution risks regarding pending NCLT merger approval
Key Highlights
Consolidated PAT increased 23.2% YoY to ₹1.21 Cr (₹120.99 Lacs) vs ₹0.98 Cr in Q1 FY26
Share of profit from 29.76% associate grew 61.5% YoY to ₹0.92 Cr (₹91.66 Lacs)
Standalone revenue from operations dropped 91.6% YoY to ₹0.62 Cr (₹61.57 Lacs) vs ₹7.36 Cr
Consolidated Basic and Diluted EPS stood at ₹1.11 compared to ₹0.90 in the previous year quarter
Scheme of merger with Agribiotech Industries Limited is pending before NCLT Jaipur following stock exchange observation letter
👀 What to Watch
Track the progress of NCLT approvals for the merger with Agribiotech Industries Limited and look for operational revenue recovery in standalone distillery/trading operations in upcoming quarters.
Q1 FY27 Cons. PAT Up 23.2% YoY to ₹1.21 Cr; Standalone Revenue Down 91.6% to ₹0.62 Cr
For Q1 ended June 30, 2026, Agribio Spirits reported a 91.6% YoY decline in standalone revenue from operations to ₹61.57 lakhs compared to ₹736.31 lakhs in Q1 FY26. Standalone net profit declined 42.7% YoY to ₹23.75 lakhs from ₹41.46 lakhs. On a consolidated basis, net profit grew 23.2% YoY to ₹120.99 lakhs (₹1.21 crore), largely driven by a ₹91.66 lakhs share of profit from its associate company and a ₹40.16 lakhs deferred tax credit. The company's proposed merger with Agribiotech Industries Limited remains pending before the NCLT Jaipur.
Confidence: HIGH
What changedQ1 FY27 results revealed a severe decline in standalone operational revenue, with consolidated profitability sustained primarily by associate company contributions and tax credits.
Why it mattersThe steep operational contraction in standalone business highlights core revenue volatility and makes consolidated performance heavily dependent on associate earnings until the ongoing merger is completed.
Standalone Revenue (Q1 FY27): ₹61.57 lakhsStandalone PAT (Q1 FY27): ₹23.75 lakhsConsolidated PAT (Q1 FY27): ₹120.99 lakhsShare of Profit from Associate: ₹91.66 lakhsConsolidated Diluted EPS: ₹1.11
📅 Short termMarket sentiment may stay cautious given the 91.6% slump in standalone operational revenue despite growth in consolidated net profit.
📈 Long termLong-term trajectory depends on operational stabilization and final NCLT clearance for the merger with Agribiotech Industries.
⚠ Risk flags
- Severe decline in standalone revenue (-91.6% YoY)
- Heavy reliance on associate entity earnings for consolidated profitability
- Pending regulatory and NCLT approval for the merger
Key Highlights
Standalone revenue from operations fell 91.6% YoY to ₹61.57 lakhs from ₹736.31 lakhs in Q1 FY26
Standalone net profit declined 42.7% YoY to ₹23.75 lakhs compared to ₹41.46 lakhs in the prior-year period
Consolidated net profit stood at ₹120.99 lakhs, supported by ₹91.66 lakhs in associate profit share
Consolidated EPS came in at ₹1.11 per share versus ₹0.90 per share in Q1 FY26
Scheme of merger with Agribiotech Industries Limited is currently pending NCLT approval
👀 What to Watch
Track the recovery of standalone operating revenues in upcoming quarters and monitor NCLT hearing dates regarding the merger with Agribiotech Industries.
